Biotech news for Wednesday, July 8, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Enlivex ( ENLV ) said on Tuesday it will implement a 1-for-15 reverse stock split, with shares trading on a split-adjusted basis beginning July 9, 2026. The reverse split will reduce the company's issued and outstanding ordinary shares to approximately 16.8M f…
Arkadiusz Warguła MeiraGTx Holdings ( MGTX ) on Tuesday announced an agreement with Oberland Capital Management LLC to receive up to $400M in funding from the private investment firm to support the development of its gene therapy candidates. Shares of the comp…
Shares of Agios Pharmaceuticals ( AGIO ) traded higher in the premarket on Tuesday after the U.S. FDA granted priority review for its marketing application seeking a label expansion for its lead product, Pyrukynd, in sickle cell disease. The Massachusetts-base…
Richard Drury Compass Pathways ( CMPS ) added ~8% in early premarket trading on Tuesday after the U.K.-based biotech announced additional data from a second ongoing late-stage trial for its psychedelic therapy COMP360 against treatment-resistant depression. Th…
Levicept Ltd ( ALDX ) announced the appointment of Darlene Deptula-Hicks as CFO. She succeeds current acting CFO Nicholas Stern, who is departing the company. The strategic C-suite expansion follows exceptional Phase II data for Levicept's lead candidate, LEVI…
AbbVie ( ABBV ) on Monday revised its second quarter guidance, with the pharma giant saying earnings for Q2 are expected to include acquired IPR&D and milestones expense of $291 million on a pre-tax basis, representing an unfavorable impact of $0.17 per sh…
Vertex Pharmaceuticals ( VRTX ) will acquire Crinetics Pharmaceuticals ( CRNX ) for a total equity value of about $10B, or nearly $8.8B net of estimated cash acquired, both companies said on Monday. Under the deal, which is anticipated to close in the third qu…
Longeveron ( NASDAQ: LGVN ) said on Monday it appointed Marie Washburn as senior vice president and chief financial officer, effective July 13, succeeding Lisa Locklear. Washburn has served as the company's VP and corporate controller since November 2025. She…
Patients infected with the Bundibugyo strain of Ebola have begun receiving experimental treatments in a World Health Organization-sponsored clinical trial aimed at improving care for the rare viral disease, which has claimed more than 500 lives in the Democrat…
Corbus Pharmaceuticals Holdings ( CRBP ) announced the appointment of Leonardo Viana Nicacio as Chief Medical Officer. Nicacio brings over 20 years of pharmaceutical and oncology experience, notably serving as VP of Clinical Development at Seagen, where he led…
Invivyd ( IVVD ) received a notice from the U.S. Food and Drug Administration terminating the emergency use authorization for PEMGARDA, its monoclonal antibody for COVID-19 prevention, effective June 29, 2027. The termination follows the U.S. Department of Hea…
Regeneron Pharmaceuticals ( REGN ) expects to record an acquired in-process research and development charge of around $127M on a pretax basis for the second quarter of 2026. This charge relates to up-front and opt-in payments in connection with collaboration a…